Although neurotrophins have been assessed as candidate therapeutic agents for neural complications of diabetes, their involvement in diabetic retinopathy has not been fully characterized. We found that the protein and mRNA levels of brain-derived neurotrophic factor (BDNF) in streptozotocin-induced diabetic rat retinas were reduced to 49% (P < 0.005) and 74% (P < 0.05), respectively, of those of normal control animals. In addition, dopaminergic amacrine cells appeared to be degenerating in the diabetic rat retinas, as revealed by tyrosine hydroxylase (TH) immunoreactivity. Overall TH protein levels in the retina were decreased to one-half that of controls (P < 0.01), reflecting reductions in the density of dopaminergic amacrine cells and the intensity of TH immunoreactivity within them. To confirm the neuropathological implications of BDNF reduction, we administered BDNF protein into the vitreous cavities of diabetic rats. Intraocular administration of BDNF rescued dopaminergic amacrine cells from neurodegeneration and counteracted the downregulation of TH expression, demonstrating its therapeutic potential. These findings suggest that the early retinal neuropathy of diabetes involves the reduced expression of BDNF and can be ameliorated by an exogenous supply of this neurotrophin.

Download full-text PDF

Source
http://dx.doi.org/10.2337/diabetes.53.9.2412DOI Listing

Publication Analysis

Top Keywords

dopaminergic amacrine
16
amacrine cells
16
brain-derived neurotrophic
12
neurotrophic factor
12
early retinal
8
retinal neuropathy
8
therapeutic potential
8
diabetic rat
8
rat retinas
8
bdnf
5

Similar Publications

Purpose: This study investigates alterations in intrinsically photosensitive retinal ganglion cells (ipRGCs) and dopaminergic amacrine cells (DACs) in lid suture myopia (LSM) rats.

Methods: LSM was induced in rats by suturing the right eyes for 4 weeks. Double immunofluorescence staining of ipRGCs and DACs in whole-mount retinas was performed to analyze changes in the density and morphology of control, LSM, and fellow eyes.

View Article and Find Full Text PDF

Age-related effects of optineurin deficiency in the mouse eye.

Vision Res

November 2024

Duke Eye Center, Department of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address:

Optineurin (OPTN) is a gene associated with familial normal tension glaucoma (NTG). While NTG involves intraocular pressure (IOP)-independent neurodegeneration of the visual pathway that progresses with age, how OPTN dysfunction leads to NTG remains unclear. Here, we generated an OPTN knockout mouse (Optn) model to test the hypothesis that a loss-of-function mechanism induces structural and functional eye deterioration with aging.

View Article and Find Full Text PDF
Article Synopsis
  • - Neurodegenerative retinal diseases like glaucoma and diabetic retinopathy involve the gradual death of retinal ganglion cells (RGCs), driven by mitochondrial dysfunction, oxidative stress, and decreased energy production.
  • - Familial dysautonomia (FD) also leads to RGC degeneration, revealing disruptions in mitochondrial structures and energy metabolism that may impact overall visual health, with specific changes in the serum and stool metabolomes indicating systemic deficiencies.
  • - The study investigated alterations in retinal metabolites and focused on dopaminergic amacrine cells, which influence RGC activity, using advanced techniques like NMR spectroscopy and mass spectrometry to link these changes to the progressive loss of RGCs in an FD mouse model.
View Article and Find Full Text PDF

Impaired dopamine signaling in early diabetic retina: Insights from D1R and D4R agonist effects on whole retina responses.

Exp Eye Res

October 2024

Department of Physiology, University of Arizona, Tucson, AZ, USA; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, USA. Electronic address:

The retina has low dopamine levels early in diabetes. To determine how low dopamine levels affected dopamine signaling, the effects of dopamine receptor agonists and mRNA localization were measured after 6 weeks of diabetes. Whole retina ex vivo electroretinogram (ERG) recordings were used to analyze how dopamine type 1 receptor (D1R) and type 4 (D4R) agonists change the light-evoked retinal responses of non-diabetic and 6-week diabetic (STZ injected) mouse retinas.

View Article and Find Full Text PDF

Modulating amacrine cell-derived dopamine signaling promotes optic nerve regeneration and preserves visual function.

Sci Adv

August 2024

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou 510060, China.

As part of the central nervous system, the optic nerve, composed of axons from retinal ganglion cells (RGCs), generally fails to regenerate on its own when injured in adult mammals. An innovative approach to promoting optic nerve regeneration involves manipulating the interactions between amacrine cells (ACs) and RGCs. Here, we identified a unique AC subtype, dopaminergic ACs (DACs), that responded early after optic nerve crush by down-regulating neuronal activity and reducing retinal dopamine (DA) release.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!